PSIAC

Literaturverzeichnis


Wen Z. Drug Metab Dispos. Mar 2007; 35(3): 371-80 Pubmed [4687]
Wen ZP. J Clin Pharm Ther. Apr 2017; 42(2): 221-227 Pubmed [7297]
Wenk M. Br J Clin Pharmacol. Apr 2004; 57(4): 495-9 Pubmed, Volltext, DOI [3596]
Wenning GK. Mov Disord. Sep 1995; 10(5): 664-7 Pubmed [6841]
Wenning LA. Antimicrob Agents Chemother. Jul 2009; 53(7): 2852-6 Pubmed [6232]
Wenning LA. Antimicrob Agents Chemother. Sep 2008; 52(9): 3253-8 Pubmed [6874]
Wenzel-Seifert K. Dtsch Arztebl Int. Oct 2011; 108(41): 687-93 Pubmed, Volltext, DOI [500]
Wenzel-Seifert K. Pharmacopsychiatry. Nov 2010; 43(7): 279-81 Pubmed [3517]
Wenzel-Seifert K. Psychopharmakotherapie. Aug 2013; 20(4): 148–57 Pubmed [11]
Werner D. Am J Cardiol. Nov 2004; 94(10): 1319-21 Pubmed [3961]
Werner M. Clin Chim Acta. Jun 1995; 237(1-2): 107-54 Pubmed [5452]
Werner U. Clin Pharmacol Ther. Aug 2003; 74(2): 130-7 Pubmed [3364]
Werth B. Schweiz Med Wochenschr. Apr 1995; 125(15): 731-4 Pubmed [5037]
Weschules DJ. Pain Med. Apr 2008; 9(3): 315-44 Pubmed [3423]
Wesnes K. Eur J Clin Pharmacol. Jan 1997; 52(5): 351-8 Pubmed [1790]
Wesnes KA. Br J Clin Pharmacol. Feb 2000; 49(2): 110-7 Pubmed, Volltext, DOI [2884]
Wessler JD. J Am Coll Cardiol. Jun 2013; 61(25): 2495-502 Pubmed [7761]
West A. Adverse effects of lithium treatment. BMJ (1977) 2, 642 [893]
West JM. Anesth Analg. Jul 1987; 66(7): 693-4 Pubmed [1897]
Westdorp H. J Pain Symptom Manage. Apr 2018; 55(4): e6-e8 Pubmed [7662]
Westervelt FB Jr. JAMA. Feb 1974; 227(5): 557 Pubmed [639]
Westhervelt und Atuk (1974) JAMA 227,557 [876]
Westlake RJ, Rastegar A. Hyperpyrexia from drug combinations. JAMA (1973) 225, 1250 [951]
Westlake RJ, Rastegar A., JAMA (1973) 225, 1250 [624]
Westphal K. Clin Pharmacol Ther. Jul 2000; 68(1): 6-12 Pubmed [4542]
Westphal K. Clin Pharmacol Ther. Oct 2000; 68(4): 345-55 Pubmed [6166]
Wetzels JF. Nephrol Dial Transplant. Jan 1989; 4(11): 939-42 Pubmed [1775]
Wheatley D. Arch Gen Psychiatry. Mar 1972; 26(3): 229-33 Pubmed [553]
White CM. J Clin Pharmacol. Sep 2019; 59(9): 1165-1169 Pubmed [8056]
White PF. Anesthesiology. Feb 1975; 42(2): 179-86 Pubmed [5353]
White SI. Br J Dermatol. Jan 1996; 134(1): 188-9 Pubmed [776]
White WB. Arch Intern Med. Sep 1986; 146(9): 1833-4 Pubmed [637]
White. Lancet (1965) ii, 441 [554]
Whittington HG. Am J Psychiatry. Jun 1969; 125(12): 1725-9 Pubmed [1301]
WHO. International travel and health: vaccination, requirements and health advise. Geneva : WHO 2001 [1440]
WHO. International travel and health: vaccination, requirements and health advise. Geneva: WHO 2001 [905]
Wiciński M. Curr Opin Hematol. Jan 2018; 25(1): 22-28 Pubmed [8037]
Wiegman DJ. AIDS. Jun 2009; 23(9): 1184-5 Pubmed [3090]
Wierzbicki AS. QJM. Oct 1997; 90(10): 631-4 Pubmed [3959]
Wiesinger H. Br J Clin Pharmacol. Dec 2015; 80(6): 1399-410 Pubmed [4596]
Wietholtz H. Eur J Clin Pharmacol. Jan 1989; 36(4): 401-6 Pubmed [727]
Wigen CL. Clin Infect Dis. Jun 2002; 34(12): 1651-2 Pubmed [2025]
Wilby KJ. Ann Hepatol. Mar 2012; 11(2): 179-85 Pubmed [6325]
Wilby KJ. Eur J Drug Metab Pharmacokinet. Dec 2018; 43(6): 637-644 Pubmed [6920]
Wilcock GK. Lancet. Apr 1987; 1(8538): 929-30 Pubmed [2387]
Wilcox JB. N Z Med J. Sep 1981; 94(692): 235-6 Pubmed [5308]
Wilder BJ. Neurology. Sep 1978; 28(9 Pt 1): 892-6 Pubmed [2458]
Wilkins E. J HIV Ther. Nov 2004; 9(4): 87-91 Pubmed [7115]
Willcox WH. Br Med J. Mar 1920; 1(3090): 392-7 Pubmed, Volltext [663]
Willcox Wh. The nature, revention and treatment of hear pyrexia: The clinical aspect. BMJ (81920) 1, 392-7 [2058]
Williams AM. Ment Health Clin. Aug 2018; 8(5): 208-213 Pubmed [7931]
Williams CS. Ann Pharmacother. Feb 2000; 34(2): 255-7 Pubmed [5564]
Williams D. Clin Pharmacokinet. Jan 2002; 41(5): 343-70 Pubmed [4728]
Williams JA. Drug Metab Dispos. Nov 2002; 30(11): 1266-73 Pubmed [4671]
Williams JM. Cancer Epidemiol Biomarkers Prev. Oct 2010; 19(10): 2582-9 Pubmed, Volltext, DOI [375]
Williams SA. J Clin Psychiatry. Jan 1996; 57 Suppl 1: 7-11 Pubmed [2290]
Williams SE. Tubercle. Mar 1985; 66(1): 49-54 Pubmed [6863]
Williamson B. Antimicrob Agents Chemother. Dec 2013; 57(12): 6366-9 Pubmed, Volltext, DOI [430]
Williamson KM. Clin Pharmacol Ther. Mar 1998; 63(3): 316-23 Pubmed [6097]
Willmore LJ. Epilepsia. Feb 2009; 50(2): 163-73 Pubmed [2077]
Wilmink T. Drug Saf. Jun 1996; 14(6): 406-23 Pubmed [5025]
Wilner et al. (1996) Eur Neuropsychopharmacol 6 (Suppl 3), 38 [2498]
Wilner et al. Biol Psychiatry (1991) 29, 354S [2298]
Wilner KD, DeMattos SB, Anziano RJ, Apseloff G, Gerber N. Lack of CYP 2D6 inhibition by ziprasidone in healthy volunteers. Biol Psychiary (1997) 42, 42S [2495]
Wilner KD, Hansen RA, Folger CJ, Geoffroy P. The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid. Br J Clin Pharmacol (2000) 49 (Suppl1), 57S-60S [2493]
Wilson et al. N Engl J Med (1970) 282, 1063-1067 [1590]
Wind S. Clin Drug Investig. Mar 2014; 34(3): 173-82 Pubmed [7445]
Wind S. Clin Pharmacokinet. Mar 2017; 56(3): 235-250 Pubmed [7755]
Windorfer A Jr. Neuropadiatrie. Feb 1977; 8(1): 29-41 Pubmed [1048]
Wingård L. J Affect Disord. Aug 2017; 217: 16-23 Pubmed [4592]
Winsemius A. J Clin Pharmacol. Sep 2014; 54(9): 1038-47 Pubmed [3960]
Winter H. Antimicrob Agents Chemother. Feb 2015; 59(2): 1219-24 Pubmed [5199]
Winter HR. Clin Pharmacol Ther. Dec 2004; 76(6): 579-87 Pubmed [5555]
Winter HR. Drug Metab Dispos. Aug 2000; 28(8): 865-8 Pubmed [4453]
Winter HR. Hum Psychopharmacol. Oct 2007; 22(7): 469-76 Pubmed [2826]
Winton JC. Am J Med Sci. Feb 2013; 345(2): 160-2 Pubmed [3859]
Wire MB. Clin Pharmacokinet. Jan 2006; 45(2): 137-68 Pubmed [4805]
Wiśniowska B. BMC Pharmacol Toxicol. Mar 2016; 17: 12 Pubmed, Volltext, DOI [4300]
Wit FW. AIDS. Dec 2001; 15(18): 2423-9 Pubmed [7093]
Witmer DR. Drug Intell Clin Pharm. Jun 1984; 18(6): 483-6 Pubmed [6794]
Witt et al. Ann Pharmacother (1993) 27, 1463-4 [786]
Wittmann et al. Neuro Endocrinol Lett. 2010 Apr 29;31(2):203-207 [2210]
WITTON K. Am J Psychiatry. Feb 1965; 121: 812-3 Pubmed [573]
Wodak J. Med J Aust. Dec 1972; 2(23): 1277-82 Pubmed [1265]
Woelk H. Phytomedicine. Feb 2010; 17(2): 94-9 Pubmed [3638]
Wójcikowski et al. Pharmacol Rep. 2009 Sep-Oct;61(5):851-8 [1822]
Wójcikowski J. Biochem Pharmacol. Jul 2014; 90(2): 188-95 Pubmed [145]
Wójcikowski J. Biochem Pharmacol. Oct 2010; 80(8): 1252-9 Pubmed [90]
Wójcikowski J. Br J Pharmacol. Apr 2003; 138(8): 1465-74 Pubmed, Volltext, Nature [2270]
Wójcikowski J. Drug Metab Dispos. Mar 2006; 34(3): 471-6 Pubmed [214]
Wójcikowski J. Eur Neuropsychopharmacol. May 2004; 14(3): 199-208 Pubmed [177]
Wójcikowski J. Pharmacol Rep. Dec 2014; 66(6): 1122-6 Pubmed [1481]
Wójcikowski J. Pharmacol Rep. Sep 2009; 61(5): 851-8 Pubmed [422]
Wójcikowski J. Pol J Pharmacol. Jul 2002; 54(4): 407-10 Pubmed [1178]
Wójcikowski, Daniel. Pharmacol Rep. 2009 Sep-Oct;61(5):851-8 [2074]
Wojtczak A. Pharmacol Rep. Jun 2014; 66(3): 511-4 Pubmed [1441]
Wolf (2006) Drugs Res Dev 7:163-172 [2794]
Wolfe EJ. Pharmacotherapy. May 1997; 17(3): 591-8 Pubmed [7291]
Wolfgang Forth, Allgemeine und spezielle Pharmakologie und Toxikologie.Mar 2018: 579-580 [2611]
Wolter K. Eur J Clin Pharmacol. Jan 1994; 47(2): 207-8 Pubmed [6047]